Human papillomavirus testing in cervical cancer screening
- PMID: 15870829
- PMCID: PMC2362052
- DOI: 10.1038/sj.bjc.6602580
Human papillomavirus testing in cervical cancer screening
Comment on
-
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening.Br J Cancer. 2005 May 9;92(9):1800-2. doi: 10.1038/sj.bjc.6602541. Br J Cancer. 2005. PMID: 15827553 Free PMC article.
-
Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case-control study in the UK.Br J Cancer. 2005 May 9;92(9):1794-9. doi: 10.1038/sj.bjc.6602538. Br J Cancer. 2005. PMID: 15827556 Free PMC article.
References
-
- Bulkmans NWJ, Rozendaal L, Snijders PJF, Voorhorst FJ, Boeke AJ, Zandwijken GR, van Kemenade FJ, Verheijen RH, Groningen K, Boon ME, Keuning HJ, van Ballegooijen M, van den Brule AJ, Meijer CJLM (2004) POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 110: 94–101 - PubMed
-
- Chua KL, Hjerpe A (1995) Polymerase chain reaction analysis of human papillomavirus in archival cervical cytologic smears. Anal Quant Cytol Histol 17: 221–229 - PubMed
-
- Clavel C, Cucherousset J, Lorenzato M, Caudroy S, Nou JM, Nazeyrollas P, Polette M, Bory JP, Gabriel R, Quereux C, Birembaut P (2004) Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer 90: 1803–1808 - PMC - PubMed
-
- Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, van Ballegooijen M, van den Akker E (1999) A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 3: 1–196 - PubMed
